Edinburgh veterinary diagnostics firm raises $3.6m
MI:RNA has completed an oversubscribed funding round, raising $3.6m via venture capital-led financing.
The Edinburgh-based molecular diagnostics company, which uses biomarkers and advanced modelling to diagnose veterinary disease earlier, previously secured $4m in a Series A round in July 2024.
The latest funding attracted participation from existing investors including NovaQuest, Kyoritsu Holdings Corporation, VANE Angel Syndicate, Animal Health Angels, Equity Gap, Gabriel and Scottish Enterprise, as well as new investors Holst... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
